3.62

4.23% -0.16

After Hours: 3.67 0.05 +1.38%

Voyager Therapeutics Inc (VYGR)

Overview News Price History Option Chain Financials Discussions Forecast

Voyager Therapeutics Inc stock is traded at $3.62, with a volume of 556.18K. It is down -4.23% in the last 24 hours and up +8.71% over the past month. Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Previous Close:

$3.78

Open:

$3.79

24h Volume:

556.18K

Relative Volume:

0.98

Market Cap:

$218.73M

Revenue:

$40.37M

Net Income/Loss:

$-119.72M

P/E Ratio:

-1.7743

EPS:

-2.0402

Net Cash Flow:

$-135.06M

1W Performance:

+1.12%

1M Performance:

+8.71%

6M Performance:

-9.95%

1Y Performance:

+13.12%

1-Day Range:

$3.61

$3.811

1-Week Range:

$3.445

$3.905

52-Week Range:

$2.8838

$5.55

Voyager Therapeutics Inc Stock (VYGR) Company Profile

Name

Voyager Therapeutics Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

857-259-5340

Address

75 HAYDEN AVENUE, LEXINGTON, MA

Employee

141

Twitter

@VoyagerTx

Next Earnings Date

2026-08-05

Latest SEC Filings

VYGR's Discussions on Twitter

Compare VYGR vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VYGR Voyager Therapeutics Inc	3.62	211.47M	40.37M	-119.72M	-135.06M	-2.0402
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-25	Initiated	Cantor Fitzgerald	Overweight
Dec-02-24	Initiated	Citigroup	Buy
Nov-29-24	Resumed	Wedbush	Outperform
Oct-16-24	Initiated	Leerink Partners	Outperform
Mar-26-24	Initiated	Guggenheim	Buy
Mar-19-24	Initiated	H.C. Wainwright	Buy
Mar-07-24	Initiated	Citigroup	Buy
Jan-02-24	Upgrade	Wells Fargo	Equal Weight → Overweight
May-10-23	Initiated	Truist	Buy
Mar-10-23	Initiated	Oppenheimer	Outperform
Oct-07-21	Upgrade	Robert W. Baird	Neutral → Outperform
Feb-26-21	Downgrade	Robert W. Baird	Outperform → Neutral
Feb-03-21	Downgrade	BTIG Research	Buy → Neutral
Feb-03-21	Downgrade	Wedbush	Outperform → Neutral
Dec-24-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Dec-23-20	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-11-20	Downgrade	Oppenheimer	Outperform → Perform
Nov-10-20	Downgrade	Raymond James	Strong Buy → Outperform
Nov-10-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Mar-19-20	Initiated	The Benchmark Company	Buy
Feb-06-20	Initiated	Oppenheimer	Outperform
Nov-15-18	Upgrade	Raymond James	Outperform → Strong Buy
Sep-10-18	Resumed	BTIG Research	Buy
Sep-10-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-04-18	Initiated	H.C. Wainwright	Buy
Mar-12-18	Downgrade	Evercore ISI	Outperform → In-line
Mar-12-18	Downgrade	Wedbush	Outperform → Neutral
Feb-02-18	Initiated	Morgan Stanley	Overweight
Nov-28-17	Resumed	Piper Jaffray	Overweight
Oct-31-17	Initiated	Robert W. Baird	Outperform
Oct-27-17	Initiated	Canaccord Genuity	Buy
Oct-23-17	Reiterated	Stifel	Buy
Oct-12-17	Initiated	Raymond James	Outperform
Aug-17-17	Initiated	Evercore ISI	Outperform
Jul-28-17	Resumed	Stifel	Buy

View All

Voyager Therapeutics Inc Stock (VYGR) Latest News

Jul 01, 2026

Enterprise value to revenue forward of Voyager Therapeutics, Inc. – NASDAQ:VYGR - TradingView

Jul 01, 2026

Jun 30, 2026

Voyager Therapeutics (VYGR) is Amongst the Best Stocks Under $10, With More Than 50% Upside - Insider Monkey

Jun 30, 2026

Price to sales forward of Voyager Therapeutics, Inc. – NASDAQ:VYGR - TradingView

Jun 30, 2026

Price to sales forward of Voyager Therapeutics, Inc. – FWB:VT6 - TradingView

Jun 30, 2026

Enterprise value to revenue forward of Voyager Therapeutics, Inc. – FWB:VT6 - TradingView

Jun 30, 2026

Price to earnings forward of Voyager Therapeutics, Inc. – NASDAQ:VYGR - TradingView

Jun 30, 2026

Jun 29, 2026

Enterprise value to EBITDA forward of Voyager Therapeutics, Inc. – NASDAQ:VYGR - TradingView

Jun 29, 2026

Price to book forward of Voyager Therapeutics, Inc. – FWB:VT6 - TradingView

Jun 29, 2026

Voyager to present Alzheimer’s gene therapy data at AAIC - Investing.com UK

Jun 29, 2026

Voyager to present Alzheimer’s gene therapy data at AAIC By Investing.com - Investing.com Australia

Jun 29, 2026

H.C. Wainwright Reaffirms Their Buy Rating on Voyager Therapeutics (VYGR) - The Globe and Mail

Jun 26, 2026

Jun 25, 2026

Voyager Therapeutics, Inc. Actuals & Estimates (MUN:VT6) - TradingView

Jun 25, 2026

VT6 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 18, 2026